Skip to main contentSkip to navigation
Sirius Investors
Apexigen, Inc.

Apexigen, Inc.

APGN
NASDAQ•Healthcare

Market Capitalization & Enterprise Value

Research-grade valuation history for APGN. Track market capitalization versus enterprise value to see the impact of net debt and share changes. Use the interactive chart to explore different horizons; the table updates accordingly to support auditability and export.

Quick links:Overview•Financial Metrics•Technicals•Returns•Financials•Performance

Market Cap & Enterprise Value

Comparison of market capitalization and enterprise value over time

Market Cap

Market Capitalization = Stock Price × Number of Shares Outstanding. Represents the total value of a company's equity.
13.49M
-95.92% over period
CAGR: -79.81%
Compound Annual Growth Rate - The mean annual growth rate over time, accounting for compounding effects.

Enterprise Value

Enterprise Value = Market Cap + Total Debt - Cash and Cash Equivalents. Represents the total value of a company including its debt.
-1.20M
-100.39% over period
CAGR: NaN%
Compound Annual Growth Rate - The mean annual growth rate over time, accounting for compounding effects.

Market Cap History

Investor Valuation Insights

As of Jun 30, 2023

EV/EBITDA

Distorted

-0.20x

Negative EV/EBITDA usually means negative EBITDA; compare with revenue and cash flow metrics.

EV vs Market Cap Spread

-14.70M

EV is -108.9% vs equity value

Capital Structure Signal

Net Cash Profile

EV premium trend: -101.6 pp vs earliest data

Additional Multiples

EV/Sales: 0.00x

Net Debt/EBITDA: 1.52x

Share count change in dataset: -36.32%

Interpretation guide: EV/EBITDA compares total firm value (debt + equity - cash) to operating earnings. Lower is usually cheaper, but always benchmark against peers, growth rate, margins, and cyclicality.

Market Cap & Enterprise Value Data

Free users can view the latest 3 records. Upgrade to see full history.

Upgrade
DateMarket CapEnterprise ValueStock PriceShares
Dec 31, 202213.49M-1.20M$0.6819.79M
Dec 31, 2021311.02M288.08M$10.0131.07M
Dec 31, 2020330.90M306.77M$10.6531.07M

Enterprise Value Analysis

Price Change (Dec 2021 to Dec 2022)

The stock price has decreased from Dec 2021 to Dec 2022.
-93.19%

Recent Volatility

The stock price has been relatively volatile over the last 3 periods, indicating a higher risk profile.
0.44

Risk-Adjusted Return

The stock's returns do not compensate for its risk level, suggesting a poor risk-reward profile.
-1.14

Market Cap Change (Dec 2021 to Dec 2022)

The company's market capitalization has decreased from Dec 2021 to Dec 2022.
-95.66%

Enterprise Value Change (Dec 2021 to Dec 2022)

The company's enterprise value has decreased from Dec 2021 to Dec 2022, suggesting a decline in the company's total economic value.
-100.42%

Market Cap vs. Enterprise Value

A lower enterprise value growth rate compared to market cap growth could suggest that the company is reducing debt or increasing cash reserves.
Market Cap Growth > EV Growth

Market Cap CAGR

The Compound Annual Growth Rate (CAGR) of market capitalization represents the mean annual growth rate over the entire available history (3 periods), accounting for compounding effects.
-79.81%

Enterprise Value CAGR

The Compound Annual Growth Rate (CAGR) of enterprise value represents the mean annual growth rate over the entire available history (3 periods), accounting for compounding effects.
NaN%